NMT1 and lung carcinoma: NMT1, which is upregulated in various cancers, including oral squamous cell carcinoma (OSCC) [154], liver cancer [155], lung cancer [19], breast cancer (BrCa) [156], osteosarcoma [157], and bladder cancer [158], is frequently associated with poor prognosis [159].